ES2087279T3 - El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis. - Google Patents

El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.

Info

Publication number
ES2087279T3
ES2087279T3 ES91900992T ES91900992T ES2087279T3 ES 2087279 T3 ES2087279 T3 ES 2087279T3 ES 91900992 T ES91900992 T ES 91900992T ES 91900992 T ES91900992 T ES 91900992T ES 2087279 T3 ES2087279 T3 ES 2087279T3
Authority
ES
Spain
Prior art keywords
prostatitis
psoriasis
treatment
giberelins
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900992T
Other languages
English (en)
Inventor
Per Oden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2087279T3 publication Critical patent/ES2087279T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P27/00—Preparation of compounds containing a gibbane ring system, e.g. gibberellin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL USO DE GIBBERELINA ACTIVA PARA LA PREPARACION DE UN COMPUESTO FARMACEUTICO PARA EL TRATAMIENTO DE LA PROSTATITIS Y/O PSORIASIS.
ES91900992T 1989-12-12 1990-12-10 El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis. Expired - Lifetime ES2087279T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK627289A DK627289D0 (da) 1989-12-12 1989-12-12 Anvendelse af bicyclononanderivater

Publications (1)

Publication Number Publication Date
ES2087279T3 true ES2087279T3 (es) 1996-07-16

Family

ID=8148421

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900992T Expired - Lifetime ES2087279T3 (es) 1989-12-12 1990-12-10 El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.

Country Status (11)

Country Link
EP (1) EP0504254B1 (es)
JP (1) JPH05502227A (es)
KR (1) KR920703088A (es)
AT (1) ATE136465T1 (es)
AU (1) AU648529B2 (es)
CA (1) CA2069002A1 (es)
DE (1) DE69026511T2 (es)
DK (1) DK627289D0 (es)
ES (1) ES2087279T3 (es)
NO (1) NO922136D0 (es)
WO (1) WO1991008751A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ285379B6 (cs) * 1992-12-18 1999-07-14 Merck & Co., Inc. Farmaceutické prostředky pro léčení prostatitidy
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
FR2707646A1 (fr) * 1993-07-15 1995-01-20 Univ Toulouse Procédé d'extraction et de purification de saponines hémolytiques.
JP4234198B2 (ja) * 1995-01-06 2009-03-04 オーストラリアン・バイオメディカル・カンパニー・プロプライアタリー・リミテッド 獣医学および医学用途用化合物
US7098189B2 (en) * 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
EP1587505B1 (en) * 2002-12-16 2010-07-21 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
JP5615484B2 (ja) * 2008-01-15 2014-10-29 株式会社 エス・ネット ５α‐リダクターゼ阻害剤
CN102526254B (zh) * 2012-02-08 2013-12-18 李宁 一种治疗男性***炎的中药组合物
JP6761705B2 (ja) * 2016-02-01 2020-09-30 株式会社日本健康食品研究所 ５α−リダクターゼ阻害剤及び泌尿器系疾患治療・予防用組成物ならびにこれらの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424232A (en) * 1982-05-19 1984-01-03 Parkinson Richard W Treatment of herpes simplex

Also Published As

Publication number Publication date
NO922136L (no) 1992-05-29
AU648529B2 (en) 1994-04-28
DE69026511T2 (de) 1996-11-21
ATE136465T1 (de) 1996-04-15
EP0504254A1 (en) 1992-09-23
DK627289D0 (da) 1989-12-12
NO922136D0 (no) 1992-05-29
WO1991008751A1 (en) 1991-06-27
KR920703088A (ko) 1992-12-17
CA2069002A1 (en) 1991-06-13
AU6913891A (en) 1991-07-18
EP0504254B1 (en) 1996-04-10
JPH05502227A (ja) 1993-04-22
DE69026511D1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
NO905514L (no) Kombinert anti-inflammatorisk middel samt fremgangsmaate for fremstilling derav.
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
TR26389A (tr) Basincli tibbi malzeme uygulayici
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
BR9000729A (pt) Desinfetante pulverizavel para superficies; agente desinfetante
IT8920413A0 (it) Procedimento per la preparazione di l alfa glicerilfosforilcolina e l alfa glicerilfosforiletanolammina.
DK0385279T3 (da) Biologisk aktive midler samt præparater og materialer, der indeholder de biologisk aktive midler
ES2087279T3 (es) El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
IT1229491B (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
IT9067363A0 (it) Composti polifluoroalchilici azotati, procedimento per la loro preparazione e loro impiego
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
MX21871A (es) Procedimiento para la preparacion de oxadiazolil fenoxialquilisoxazoles y compuestos resultantes
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
ES2019262A4 (es) Procedimiento para el tratamiento biologico de nitratos disueltos
ES2055421T3 (es) Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.
SE8502865L (sv) Naftoxaziner, deras framstellning och anvendning
PT804199E (pt) Uso de penciclovir para o tratamento de nevralgias pos-herpeticas
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
MX173643B (es) Aparato para la mezcla de una substancia gaseosa o vaporizada
SE8802040D0 (sv) New use
ES2051916T3 (es) Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros.
KR920700539A (ko) 해중 오염방지 처리 조성물
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
BR9000897A (pt) Composicao fungicida,processo para a preparacao de compostos,processo para preparar uma composicao e para controlar fungos e uso

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0504254

Country of ref document: ES